MAP4K4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.904200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.633900E-02
Normal-vs-Stage2
9.494800E-01
Normal-vs-Stage3
5.530000E-01
Normal-vs-Stage4
5.027400E-01
Stage1-vs-Stage2
1.310370E-01
Stage1-vs-Stage3
5.587600E-01
Stage1-vs-Stage4
2.120100E-02
Stage2-vs-Stage3
4.868800E-01
Stage2-vs-Stage4
4.760400E-01
Stage3-vs-Stage4
2.737200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.546800E-01
Normal-vs-AfricanAmerican
8.996000E-01
Normal-vs-Asian
1.539830E-01
Caucasian-vs-AfricanAmerican
7.560400E-01
Caucasian-vs-Asian
1.286210E-01
AfricanAmerican-vs-Asian
4.072000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.423200E-01
Normal-vs-Female
8.092000E-01
Male-vs-Female
6.372800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.347000E-01
Normal-vs-Age(41-60Yrs)
7.957200E-01
Normal-vs-Age(61-80Yrs)
8.004200E-01
Normal-vs-Age(81-100Yrs)
4.216600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.059000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.813000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.892400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.124400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.133240E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.814000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.023000E-01
Normal-vs-Daily Drinker
3.787800E-01
Normal-vs-Weekly Drinker
9.049400E-01
Normal-vs-Occasional Drinker
7.954000E-01
Normal-vs-Social Drinker
8.497600E-01
Non Drinker-vs-Daily Drinker
6.183000E-01
Non Drinker-vs-Weekly Drinker
2.998200E-01
Non Drinker-vs-Occasional Drinker
1.557180E-01
Non Drinker-vs-Social Drinker
2.365000E-01
Daily Drinker-vs-Weekly Drinker
1.655590E-01
Daily Drinker-vs-Occasional Drinker
9.697900E-02
Daily Drinker-vs-Social Drinker
1.555030E-01
Weekly Drinker-vs-Occasional Drinker
4.837200E-01
Weekly Drinker-vs-Social Drinker
6.075200E-01
Occasional Drinker-vs-Social Drinker
8.996200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.019200E-01
Normal-vs-Grade 2
1.693430E-01
Normal-vs-Grade 3
2.452000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.584400E-02
Grade 1-vs-Grade 3
9.404600E-03
Grade 1-vs-Grade 4
7.019200E-01
Grade 2-vs-Grade 3
2.601600E-01
Grade 2-vs-Grade 4
1.693430E-01
Grade 3-vs-Grade 4
2.452000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.765200E-01
Normal-vs-NonDiabetic
8.148600E-01
Diabetic-vs-NonDiabetic
9.057600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.973800E-01
Normal-vs-NoPancreatitis
8.330000E-01
Pancreatitis-vs-NoPancreatitis
6.390200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.154800E-01
Normal-vs-N1
9.755400E-01
N0-vs-N1
4.372200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.436000E-01
Normal-vs-TP53-NonMutant
3.424000E-01
TP53-Mutant-vs-TP53-NonMutant
2.17959999999628E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
